scholarly journals New-Onset Diabetes After Renal Transplantation (NODAT): Is It a Risk Factor for Renal Cell Carcinoma or Renal Failure?

2019 ◽  
Vol 24 ◽  
pp. 62-69 ◽  
Author(s):  
Haibo Nie ◽  
Wei Wang ◽  
Yongbin Zhao ◽  
Xiaoming Zhang ◽  
Yuansong Xiao ◽  
...  
Nephron ◽  
1991 ◽  
Vol 58 (3) ◽  
pp. 354-358 ◽  
Author(s):  
Isao Ishikawa ◽  
Hirofumi Ishii ◽  
Akira Shinoda ◽  
Keita Tateishi ◽  
Aritomo Ben ◽  
...  

2017 ◽  
Vol 49 (8) ◽  
pp. 1779-1782 ◽  
Author(s):  
W.M. Bennett ◽  
E.L. Simonich ◽  
A.M. Garre ◽  
K.M. McEvoy ◽  
M.A. Farinola ◽  
...  

Nephron ◽  
1988 ◽  
Vol 50 (2) ◽  
pp. 169-170 ◽  
Author(s):  
Saleh H. Abu-Romeh ◽  
M.S. Al-Adnani ◽  
Sami Asfar

2020 ◽  
Vol 104 (11-12) ◽  
pp. 837-848
Author(s):  
Ming Li ◽  
Renge Bu

Obesity is a proven risk factor and a debated prognostic factor in renal cell carcinoma (RCC). Termed as an “obesity paradox,” the topic has churned controversies, with a few arguing of no true biological association. Suggesting otherwise, a few studies revealed adiposity-induced altered molecular and transcriptomic signatures, at both the systemic and local (tumor and peritumoral adipose tissue) levels, in RCC patients, favoring the paradox. Summarizing such studies suggests of a considerable biological support to adiposity as a promising prognostic factor in RCC patients, although much needs to be clarified before adopting it as a valuable addition to the existing prognostic model.


2013 ◽  
Vol 84 (1-2) ◽  
pp. 91-92
Author(s):  
John Samuel Banerji ◽  
Santosh Kumar Singh ◽  
Nitin Sudhakar Kekre

Sign in / Sign up

Export Citation Format

Share Document